| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689285 | European Urology | 2017 | 11 Pages |
Abstract
We examined the literature to determine the most effective treatments for advanced kidney cancer patients whose tumors are not of the clear cell subtype. The results suggest that a drug called sunitinib might be more effective than everolimus, but the statistics supporting this statement are not yet entirely reliable. Further research is required to clarify this unmet medical need.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sergio Fernández-Pello, Fabian Hofmann, Rana Tahbaz, Lorenzo Marconi, Thomas B. Lam, Laurence Albiges, Karim Bensalah, Steven E. Canfield, Saeed Dabestani, Rachel H. Giles, Milan Hora, Markus A. Kuczyk, Axel S. Merseburger, Thomas Powles,